Statesboro, Ga., Jan. 5, 2022 – Low Country Cancer Care (LCCC), is pleased to announce the opening of their new cancer center in Statesboro, Ga., located at 1601 Fair Road, Suite 900. This new clinic is the fifth LCCC location, making it easier for patients to have access to the highest quality cancer care close to where they live.

Other locations are in Savannah, Hinesville and Pooler, Ga., and Bluffton, S.C. The team consists of seven providers including four medical oncologists, one physician assistant and two nurse practitioners. LCCC offers a comprehensive range of treatments for patients diagnosed with cancer and blood disorders.

In 2020, LCCC joined the American Oncology Network, LLC (AON), a high-growth medical oncology provider with a focus on supporting the long-term viability of cancer treatment in community-based settings. The LCCC and AON partnership helps provide the best cancer care with additional services including in-house pathology and specialty pharmacy, access to a care management team and financial assistance programs to help navigate insurance coverage.

AON Chief Executive Officer Todd Schonherz said, “Low Country Cancer Care and AON believe every patient deserves access to affordable yet high-quality cancer care in the communities where they live.”

LCCC is committed to providing the community with innovative cancer care that is based on research, evidence-based medicine and focused on the whole person. Cancer patients will now have access to a diverse range of services for diagnosis, treatment, clinical trials, survivorship and patient support, giving them unparalleled access to comprehensive, integrated cancer care, close to home.

“Dr. Negrea and I are pleased to provide medical oncology and hematology services in Statesboro, so we can serve patients close to their home. Our decision to expand to better serve patients in this area continues the vision we share with AON of positively impacting patients’ lives,” said Low Country Cancer Care Medical Oncologist Dr. Rohit Bishnoi.

AON President & Chief Development Officer Brad Prechtl, MBA stated, “This expansion makes it the fourth clinic we have opened in Georgia, showing our commitment to offering patients access to the latest advancements and cancer treatments right where they live.”

###

About Low Country Cancer Care: (LCCCSav.com)
Low Country Cancer Care has five locations, including one office in Savannah and four satellite offices in Hinesville, Statesboro and Pooler, Georgia and Bluffton, South Carolina. The team includes four medical oncologists, one physician assistant and two nurse practitioners who provide a comprehensive range of treatment for patients diagnosed with cancer and blood disorders.

About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network represents 105 physicians and 79 nurse practitioners and physician assistants practicing across 16 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

For More Information, Contact:
American Oncology Network, LLC
Caroline Hewitt, Vice President of  Marketing
Caroline.Hewitt@AONcology.com

Puyallup, Wash., Jan. 3, 2022 – Partner Oncology, serving Puyallup and the Lakewood areas in oncology and hematology, recently rebranded the practice name to Panacea Oncology (Panacea). Panacea provides personalized and compassionate care, offering cancer patients in Pierce County the most advanced treatments of the highest quality.

The name was changed to show the wider scope of value and services offered. Panacea means a solution or remedy for all diseases which embodies Panacea’s mission of innovative care based on research and evidence-based treatment.

Panacea Medical Oncologist Dr. Joseph Ye said, “The available resources we have in this constantly changing world of complex diseases of oncology and blood disorders allows us to better serve our patients. We felt it was necessary to rebrand our practice to better represent the exceptional cancer care we provide right here in the communities where our patients live.”

In addition to the name change Panacea also introduced a new logo design which features all the colors from the cancer awareness ribbons. These colors represent all the indications of cancer.

AON Chief Executive Officer Todd Schonherz said, “The new Panacea identity better aligns with the clinical services offered while making a more memorable impression.”

Panacea Oncology Medical Oncologists Drs. Joseph Ye, Xinda David Wang and Weigang Tong are part of the American Oncology Network, LLC (AON)—a leading physician network helping community oncologists have greater access to more resources so patients get top-level cancer care within their communities.

###

About Panacea Oncology: (PanaceaOncology.com)
Panacea Oncology (Panacea) offers convenient access to quality cancer and hematology care for patients in Puyallup and Lakewood, Washington. A community-based practice, Panacea provides medical oncology/hematology services and infusion therapy including immunotherapy for treating cancer and other diseases.

About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network represents 105 physicians and 79 nurse practitioners and physician assistants practicing across 16 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

For More Information, Contact:
American Oncology Network, LLC
Caroline Hewitt, Vice President of  Marketing
Caroline.Hewitt@AONcology.com

Fort Myers, Fla., Dec. 16, 2021 – American Oncology Network, LLC (AON) is pleased to announce that eight research studies co-authored by AON physicians were presented at the American Society of Hematology (ASH) Annual Meeting & Exposition, held December 11-14, 2021.

Abstracts submitted for oral and poster presentations at the ASH annual meeting represent important, novel research in the field and are considered the best of the thousands of abstracts submitted. Typically, more than 5,000 scientific abstracts are submitted each year and more than 3,000 are accepted for oral and poster presentations through an extensive peer review process.

The following AON physician investigators presented their research results during poster discussions and/or presentations.

• Dr. Ruemu E. Birhiray of Hematology Oncology of Indiana, who served as co-author of a study titled an Extended Characterization of Newly Diagnosed Multiple Myeloma (NDMM) Patients with In-Class Transition (iCT) from Parenteral Bortezomib to Oral Ixazomib Proteasome Inhibitor (PI) Therapy in the Community-Based United States (US) MM-6 Study: Updated Efficacy and Safety, and Reasons for Premature Discontinuation (Abstract # 2726)
• Dr. Ralph V. Boccia of The Center for Cancer and Blood Disorders, who served as co-author of several studies titled a Phase 1b/2 Study of the First-in-Class SUMO-Activating Enzyme Inhibitor TAK-981 in Combination with Monoclonal Antibodies in Patients with Triple-Class Refractory Multiple Myeloma (Abstract # 2742) and the Efficacy and Safety of Ruxolitinib and Steroids for Treating Patients with Relapsed or Refractory Multiple Myeloma (Abstract # 2727)
• Dr. Arvind Chaudhry of Summit Cancer Centers, who presented and served as co-author of several studies titled the Efficacy and Safety of the BTK Inhibitor MK-1026 in Patients with Hematologic Malignancies: Phase 2 Study (Abstract # 3737) and a Phase 2 Study of Zanubrutinib in BTK Inhibitor – Intolerant Patients with Relapsed / Refractory B-Cell Malignancies (Abstract # 1410)
• Dr. Christopher Chay of Messino Cancer Centers, who served as co-author of a study titled BRUIN MCL-321: A Phase 3 Open-Label, Randomized Study of Pirtobrutinib Versus Investigator Choice of BTK Inhibitor in Patients with Previously Treated, BTK Inhibitor Naïve Mantle Cell Lymphoma (Trial in Progress) (Abstract # 2422)
• Dr. Victor M. Priego of The Center for Cancer and Blood Disorders, who served as co-author of several studies titled A Phase 1a/b Dose Escalation Study of the Mutation Agnostic BTK/FLT3 Inhibitor Luxeptinib (CG-806) in Patients with Relapsed or Refractory B-Cell Malignancies (Abstract # 1355) and Rusfertide (PTG-300), a Hepcidin Mimetic, Maintains Liver Iron Concentration in the Absence of Phlebotomies in Patients with Hereditary Hemochromatosis (Abstract # 943)

AON CEO Todd Schonherz said, “The physicians within our network are dedicated to bringing innovative treatment options to patients, close to home. To have eight AON physicians’ research studies being shared at this prestigious program confirms that our physicians are not only uniting in collaboration, they’re at the forefront of new discoveries and findings that will expand and improve blood disease treatment options for every patient.”

###

About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly growing AON network represents 105 physicians and 79 nurse practitioners and physician assistants practicing across 16 states. The executive management team of AON brings more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

For More Information, Contact:
American Oncology Network, LLC
Caroline Hewitt, Vice President of Marketing
Caroline.Hewitt@AONcology.com

Phoenix, Ariz., Nov. 23, 2021 – Cancer & Blood Specialists of Arizona (CBSA), a partner practice of American Oncology Network, LLC (AON) launches a new chapter of the Community Oncology Alliance Patient Advocacy Network (CPAN).

CPAN is a national advocacy organization committed to raising awareness of independent, community cancer care and the issues that affect it. CPAN plays a vital role in advocating for patients making sure cancer care is affordable and accessible in the communities where they live.

CBSA Medical Oncologist Tania Cortas, MD, CPE said, “We feel honored to be the first community oncology practice in the entire state of Arizona to partner with CPAN. At Cancer & Blood Specialists of Arizona we pride ourselves on being patient centric and joining this national advocacy group will help our patients to be able to continue to get affordable, yet high-quality cancer care close to where they live.”

“Cancer & Blood Specialists of Arizona patients, survivors, caregivers, family members, physicians, staff and community members can all play a part in helping to influence national policies that can influence cancer care within our community,” said Todd Schonherz, AON Chief Executive Officer.

There are 31 active CPAN chapters across the U.S. advocating in Washington, D.C. to make an impact on influencing policy and expressing the importance of community oncology.

Rose Gerber, Director of Patient Advocacy and Education for CPAN said, “We support the cure but we advocate for the care.” Gerber continued, “Local CPAN chapters within our community cancer centers are important to our cause of educating, engaging and activating cancer care advocates across the nation, helping to ensure patients benefit from quality, affordable and accessible cancer care.”

AON Chief Growth & Relationship Officer Shelly Glenn, added “A CPAN chapter in the Cancer & Blood Specialists of Arizona community means that Greater Phoenix Area patients will have a direct impact on major key cancer issues at a national level.”

CBSA and CPAN will work together to combat issues affecting many patients such as limitations on choice of doctors, less personalized medicine, increased hospital care costs, rising medication prices and being forced to travel for care and treatment.

###

About Cancer & Blood Specialists of Arizona: (CancerBloodSpecialistsAZ.com)
Cancer & Blood Specialists of Arizona is a community-based Medical Oncology, Gynecologic Oncology and Hematology practice providing treatment for patients diagnosed with all types of cancer and blood disorders. We are experienced physicians, nurse practitioners, nurses and clinical support staff providing compassionate, patient-centered care in Phoenix, Arizona, and surrounding areas. Our physicians have deep roots in the Greater Phoenix Area and are proud of our 40-year collective history of delivering the highest quality cancer treatment that is based on cutting-edge research.

About Community Oncology Alliance Patient Advocacy Network (CPAN): (COAAdvoacy.org)
Cancer & Blood Specialists of Arizona is a community-based Medical Oncology, Gynecologic Oncology and Hematology practice providing treatment for patients diagnosed with all types of cancer and blood disorders. We are experienced physicians, nurse practitioners, nurses and clinical support staff providing compassionate, patient-centered care in Phoenix, Arizona, and surrounding areas. Our physicians have deep roots in the Greater Phoenix Area and are proud of our 40-year collective history of delivering the highest quality cancer treatment that is based on cutting-edge research.

About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network represents 104 physicians and 78 nurse practitioners and physician assistants practicing across 16 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

For More Information, Contact:
American Oncology Network, LLC
Caroline Hewitt, Vice President of  Marketing
Caroline.Hewitt@AONcology.com

Fort Myers, Fla., Nov. 9, 2021 – American Oncology Network, LLC (AON), a high-growth national network of independent community oncologists, is pleased to announce the opening of Desert Hematology Oncology in Surprise, Ariz. The community-based practice joined AON effective Nov. 8, 2021 and is now the third practice in Arizona to partner with AON.

Desert Hematology Oncology (DHO) specializes in the diagnosis and treatment of cancer and blood disorders. DHO will offer a variety of services to enhance cancer care by providing an in-house specialty pharmacy and pathology and financial counselors to assist with insurance questions. The clinic is located at 14780 W Mountain View Blvd., Suite 211, Surprise, Ariz.

“Opening Desert Hematology Oncology as our third AON practice in Arizona is helping our mission of ensuring all patients have local access to the best cancer care. High quality, yet affordable care is now a reality for patients living in Surprise, Casa Grande, Phoenix and Gilbert,” said AON President & Chief Development Officer Brad Prechtl, MBA.

Medical Oncologist Dr. David Kahn and Nurse Practitioner Anna Birks will be providing care at DHO. The new clinic will provide infusion therapy, centralized laboratory and pathology and home delivery of oral cancer medications.

AON Chief Executive Officer Todd Schonherz added, “We are excited to have Dr. Kahn join AON, he is an experienced medical oncologist with deep roots in Arizona. He is passionate about research and making sure his patients have access to the latest technologies and treatments available.”

Dr. Kahn emphasized he has a strong history of providing top-quality cancer treatments based on medical evidence and research. “I am focused on the whole person and I value my partnership with each patient and their families.”

AON was founded by well-respected leaders in community oncology with decades of experience helping oncology practices to thrive by providing proven solutions and ensuring that everyone has access to exceptional cancer care.

###

About Desert Hematology Oncology: (DesertHematologyOncology.com)
Desert Hematology Oncology is a community-based medical oncology and hematology practice providing treatment for patients diagnosed with all types of cancer and blood disorders. Offering compassionate and personalized care to patients in Surprise, Ariz., as well as the surrounding Phoenix area. Our Board-certified providers are committed to providing quality, evidence-based oncology and hematology care.

About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network represents 104 physicians and 78 nurse practitioners and physician assistants practicing across 16 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

For More Information, Contact:
American Oncology Network, LLC
Caroline Hewitt, Vice President of  Marketing
Caroline.Hewitt@AONcology.com